Inpo leuwih ― Urang sundan

Urtikaria ilaharna muncul kalayan welts anu kacida gatelna. Kadang‑kadang dibarengan ku bengkak tina jaringan dasar. Pangobatan utamina ngalibatkeun ngahindarkeun pemicu, upami dipikanyaho. Pangobatan lini kahiji ngawengku antihistamin generasi anyar, anu tiasa ditingkatkeun dosisna upami diperlukeun. Pangobatan sanés sapertos antihistamin generasi heubeul, pameungpeuk H2, antagonis réséptor leukotrien, antihistamin anu langkung kuat, jeung kursus pondok kortikosteroid tiasa ditambah salaku dukungan tambahan. Dina kasus urticaria nu tetep aya sanajan pangobatan ieu, penderita tiasa dirujuk ka spesialis pikeun terapi tambahan sapertos omalizumab atawa cyclosporine.
Urticaria commonly presents with intensely itchy raised welts. It is sometimes accompanied by swelling of the underlying tissues. Treatment primarily involves avoiding triggers, if known. First-line medication includes newer antihistamines, which can be adjusted to higher doses if needed. Other medications like older antihistamines, H2 blockers, leukotriene receptor antagonists, stronger antihistamines, and short courses of corticosteroids can be added as extra support. In cases where urticaria persists despite these measures, patients might be referred to specialists for additional therapies such as omalizumab or cyclosporine.

Tinjauan ieu ngagariskeun tungtunan panganyarna pikeun ngubaran urtikaria sareng nawiskeun pamahaman énggal ngeunaan panyababna.
This review outlines the latest guidelines for treating urticaria and offers new understandings of its causes.

Second-generation H1-antihistamines (e.g., cetirizine, loratadine, fexofenadine), Omalizumab, Ciclosporin, and short courses only of systemic corticosteroids